Paxlovid, an antiviral therapy that is prescribed to COVID-19 patients to prevent severe illness, soon will cost more than double the $529 that the federal government had paid for the treatment.
Paxlovid, an antiviral therapy that is prescribed to COVID-19 patients to prevent severe illness, soon will become much more expensive to obtain. As the medication transitions to the commercial market, Pfizer has set the updated price for a five-day course at $1,390 — more than double the $529 that the federal government had paid for the treatment. The new pricing was announced in a letter Pfizer sent to pharmacies on Oct. 18, which was obtained by The Wall Street Journal.
Pricing for Paxlovid is based on the value it provides to patients, providers and health care systems due to its important role in helping reduce COVID-19-related hospitalizations and deaths,' Pfizer said in a statement. Last week, Pfizer announced in a release on its website that it 'amended its supply agreement with the U.S. government for Paxlovid' as the emergency use authorization -labeled medications are phased out.
The date May 11, 2023, marked the official end of the federal public health emergency related to the COVID-19 pandemic. However, the government’s declaration noted that emergency use authorizations for COVID-related products would not be affected. 'The timing to conclude the EUA is to be determined; it will not conclude on May 11, 2023, with the other declarations.' Fox News Digital reached out to Pfizer for additional comment. For more Health articles, visit www.foxnews.com/health.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial MarketNick Visser is a senior reporter on HuffPost’s breaking news team, covering the environment, U.S. politics and world news. Originally based in New York, he now lives in Sydney.
Read more »
Pfizer more than doubles price of lifesaving COVID-19 medication PaxlovidThe price of the lifesaving COVID-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic.
Read more »
COVID Treatment Paxlovid Will Cost $1,390 per CoursePfizer said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out, more than double what the government currently pays for it. The new list price, which...
Read more »
Pfizer to price COVID treatment Paxlovid at $1,390 per coursePfizer on Wednesday said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out, more than double what the government currently pays for it.
Read more »
Pfizer jacks up price of five-day course of COVID drug Paxlovid to $1,400The new cost of the drug is nearly triple the amount the US government paid during the coronavirus pandemic, according to a report.
Read more »
Pfizer Spikes Paxlovid Prices to 100 Times Cost of ProductionNone
Read more »